BioSpace News Archive

Business

CENTOGENE Signs Data Access and Collaboration Agreement with Pfizer Inc.

CENTOGENE announced a new data access and collaboration agreement with Pfizer Inc.

November 13, 2019
·
2 min read
Business

Isofol’s Board Appoints Dr. Jarl Ulf Jungnelius as New CEO of the Company

Isofol Medical AB, announced that the board of Isofol has decided that from today’s date, November 13 2019, appoint the chairman of the board, Dr Jarl Ulf Jungnelius, M.D., as CEO of the company.

November 13, 2019
·
4 min read
Job Trends

Clovis Oncology Announces Reimbursement for Rubraca® (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in Italy

Rubraca® (rucaparib) offers a new monotherapy maintenance treatment option for eligible women with relapsed, platinum-sensitive ovarian cancer, who harbor either a BRCA1/2 mutation or are BRCA wild-type

November 13, 2019
·
12 min read
Business

LG Chem Life Sciences Expands Partnership with Avacta Group plc

LG Chem selects second and third drug targets following rapid progress in first programme

November 13, 2019
·
2 min read
Policy

BrainStorm Announces Grant of a New Japanese Patent for NurOwn®

BrainStorm Cell Therapeutics Inc. announced that the Japan Patent Office has issued a Decision to Grant a Patent for BrainStorm’s Patent Application, number: 2016-548691, titled: ‘Method of Qualifying Cells.’

November 13, 2019
·
4 min read
Business

IDEAYA Biosciences, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update

Single-arm Phase 2 clinical trial may be adequate to support an NDA seeking Accelerated Approval for IDE196 monotherapy in metastatic uveal melanoma (MUM)

November 13, 2019
·
9 min read
Deals

ProteKt Therapeutics Raises $3.6 Million in Post-Incubation Financing

ProteKt Therapeutics, a biotech company developing new PKR kinase inhibitor-based therapies for neurodegenerative diseases including Alzheimer’s Disease, announced the signing of a binding agreement for a $US 3.6 million equity financing round.

November 13, 2019
·
3 min read
Drug Development

Cassiopea Announces First Patient to be Enrolled in Phase II Trial for the Treatment of Androgenetic Alopecia in Females with Clascoterone Solution

Cassiopea SpA announced that it has received approval from the German Authority BfArM and the coordinating ethical committee and will now proceed to enroll the first patient in a Phase II trial investigating clascoterone solution for the treatment of androgenetic alopecia in females.

November 13, 2019
·
6 min read
Business

Astrotech Reports First Quarter of Fiscal Year 2020 Financial Results

Astrotech Corporation reported its financial results for the first quarter of fiscal year 2020, which ended September 30, 2019.

November 13, 2019
·
6 min read
Business

Matinas BioPharma Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Initiated pre-screening of patients for Phase 2 ENHANCE-IT study of MAT9001 against Vascepa®. Enrollment to commence Q1 2020, with topline data expected H2 2020

November 13, 2019
·
8 min read